Molecular Profiling of Endometrial Malignancies

Table 1

Clinical and pathological characteristics of type I and type II endometrial carcinoma [1, 2, 4–13].

	Type I	Type II
Proportion of endometrial carcinomas	4/5	1/5
Menstrual status	Pre- and perimenopausal	Postmenopausal
Endocrine-metabolic disturbance	Present	Absent
Estrogen-associated	Yes	No
Background endometrium	Hyperplasia	Atrophy
Histological type	Endometrioid	Serous, clear cell
Tumor grade	Low	High
Depth of myometrial invasion	Superficial	Deep
Behavior	Stable/indolent	Progressive/aggressive